Numinus Wellness To Acquire Novamind In All Stock Transaction At $0.44 Per Share
Consolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus Wellness (TSX: NUMI) will be
Read more
Numinus Wellness Inc
Numinus Wellness Parts With Chief Strategy Officer, Issues 2.0 Million Shares With Separation
Numinus Wellness Inc. (TSXV: NUMI) announced on Thursday that its Chief Strategy Officer Stacey Wallin is leaving the company. The
Read more
Numinus Wellness Announces Move To Toronto Stock Exchange
Numinus Wellness (TSV: NUMI) is set to be one of the next firms listed on the Toronto Stock Exchange. The
Read more
Numinus Wellness: Eight Capital Initiates With $1.10 Price Target
Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry primer
Read more
Numinus Wellness’ Study On MDMA-Assisted Therapy For PTSD Gets Health Canada Nod
Numinus Wellness Inc. (TSXV: NUMI) announced today that it has secured approval from Health Canada to conduct its feasibility study
Read more
Psychedelics: The Eight Capital Primer
Eight Capital recently produced a primer on the psychedelic sector saying that the companies are “poised to fill a growing
Read more
Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Extract
Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this morning announced a partnership with
Read more
Numinus Wellness To Conduct $30 Million Bought Deal
Numinus Wellness (TSXV: NUMI) this morning announced that it will be raising funds again. The latest round being conducted by
Read more
Numinus Wellness Announces Expansion To Research Lab
Numinus Wellness (TSXV: NUMI) has expansion on its mind. The company this morning announced that it plans to expand its
Read more
Numinus Wellness Halts Stock For Trading Day To Announce $17 Million Financing Closing
After halting trading in its equity all day, Numinus Wellness (TSXV: NUMI) this evening finally released the much awaited news:
Read more